Carbon-11-methionine positron emission tomography imaging of chordoma

Skeletal Radiology

Volumn 33, Issue 9, 2004, Pages 524-530

  Zhang, Hong ^a,b   Yoshikawa, Kyosan ^a   Tamura, Katsumi ^a   Sagou, Kenji ^a   Tian, Mei ^a   Suhara, Tetsuya ^a   Kandatsu, Susumu ^a   Suzuki, Kazutoshi ^a   Tanada, Shuji ^a   Tsujii, Hirohiko ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

11C methionine; Carbon ion radiotherapy; Chordoma; Diagnosis; PET

Indexed keywords

CARBON; METHIONINE C 11;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CHORDOMA; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG UPTAKE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MALE; METABOLIC RATE; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; CARBON RADIOISOTOPES; CHORDOMA; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; SACRUM; SPINAL NEOPLASMS;

EID: 4544355429     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00256-004-0815-5     Document Type: Article

References (37)

1. Baratti D, Gronchi A, Pennacchioli E, et al. Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Oncol 2003; 10:291-296.
2. Mindell ER. Chordoma. J Bone Joint Surg Am 1981; 63:501-505.
3. Breteau N, Demasure M, Lescrainier J, Sabbattier R, Michenet P. Sacrococcygeal chordomas: potential role of high LET therapy. Recent Results Cancer Res 1998; 150:148-155.
4. Watkins L, Khudados ES, Kaleoglu M, Revesz T, Sacares P, Crockard HA. Skull base chordomas: a review of 38 patients, 1958-88. Br J Neurosurg 1993; 7:241-248.
5. Gay E, Sekhar LN, Rubinstein E, et al. Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery 1995; 36:887-897.
6. Al-Mefty O, Borba LA. Skull base chordomas: a management challenge. J Neurosurg 1997; 86:182-189.
7. Krayenbuhl H, Yasargil MG. Cranial chordomas. Progr Neurol Surg 1975; 6:380-434.
8. Benk V, Liebsch NJ, Munzenrider JE, Efird J, McManus P, Suit H. Base of skull and cervical spine chordomas in children treated by high-dose irradiation. Int J Radiat Oncol Biol Phys 1995; 31:577-581.
9. Castro JR, Collier JM, Petti PL, et al. Charged particle radiotherapy for lesions encircling the brain stem or spinal cord. Int J Radiat Oncol Biol Phys 1989; 17:477-484.
10. Kamada T, Tsujii H, Tsuji H, et al. Working Group for the Bone and Soft Tissue Sarcomas. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol 2002; 20:4466-4471.
11. Gambhir SS. Molecular imaging of cancer with positron emission tomography. Natl Rev Cancer 2002; 2:683-693.
12. Zhang H, Tian M, Oriuchi N, Higuch, T, Tanada S, Endo K. Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PET. Br J Radiol 2002; 75:409-416.
13. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33:1972-1980.
14. Haberkorn U, Strauss LG, Dimitrakopoulou A, et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 1991; 32:1485-1490.
15. Hautzel H, Muller-Gartne, HW. Early changes in fluorine-18-FDG uptake during radiotherapy. J Nucl Med 1997; 38:1384-1386.
16. Hoffman RM. Unbalanced transmethylation and the perturbation of the differentiated state leading to cancer. Bioessays 1990; 12:163-166.
17. 11C]-L-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging 2003; 30:868-873.
18. Kubota R, Kubota K, Yamada S, et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med 1995; 36:484-492.
19. Schaider H, Haberkorn U, Berger MR, Oberdorfer F, Morr I, van Kaick G. Application of alpha-aminoiosbutyric acid,L-methionine, thymidine and 2-fluoro-2-D-glucose to monitor effects of chemotherapy in a human colon carcinoma cell line. Eur J Nucl Med 1996; 23:55-60.
20. Higashi K, Clavo AC, Wahl RL. In vitro assessment of 2-fluoro-2-D-glucose, L-methionine, thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. J Nucl Med 1993; 34:773-779.
21. 3H]thymidine, and gallium-67. J Nucl Med 1991; 32:2118-2123.
22. Minn H, Clavo AC, Grenman R, Wahl RL. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose andL-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med 1'995; 36:252-258.
23. Stern PH, Hoffman RM. Elevated overall rates of transmethylation in cell lines from diverse human tumors. In Vitro 1984; 20:663-670.
24. Stern PH, Wallace CD, Hoffman RM. Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines. J Cell Physiol 1984; 119:29-34.
25. Wheatley DN. On the problem of linear incorporation of amino acids into cell protein. Experientia 1982; 38:818-820.
26. Weiss SW. WHO international histological classification of tumours. Histological typing of soft tissue tumours, 2nd edn. Berlin Heidelberg New York: Springer, 1994.
27. 11C]methionine. J Nucl Med 1987; 19:1037-1040.
28. 11C-methionine in breast cancer studied by PET. An association with the size of S-phase fraction. Br J Cancer 1991; 64:1121-1124.
29. Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol 1999;175(Suppl 2):57-63.
30. Hug EB, Loredo LN, Slater JD, et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 1999; 91:432-439.
31. Verstraete KL, Lang P. Post-therapeutic magnetic resonance imaging of bone tumors. Top Magn Reson Imaging 1999; 10:237-246.
32. Fletcher BD. Effects of pediatric cancer therapy on the musculoskeletal system. Pediatr Radiol 1997; 27:623-636.
33. Murphy WA Jr. Imaging bone tumors in the 1990s. Cancer 1991; 67:1169-1176.
34. Hawkins DS, Rajendran JG, Conrad EU 3rd, Bruckner JD, Eary JF. Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography. Cancer 2002; 94:3277-3284.
35. Findlay M, Young H, Cunningham D, et al. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. J Clin Oncol 1996; 14:700-708.
36. 11C]-L-methionine positron emission tomography. Clin Cancer Res 2001; 7:2269-2276.
37. Andersson T, Wilander E, Eriksson B, Lindgren PG, Oberg K. Effects of interferon on tumor tissue content in liver metastases of human carcinoid tumors. Cancer Res 1990; 50:3413-3415.